2Left A, Joanny YP. Une affection non de critc des os: hyperostose"en coule e'sur tonte la longuenr dkm membre on "me lorhe ostose"[J]. Bull Membres Soc Med Hosp Paris, 1922, 46:1141-1145.
3Wyrme-Davies R, Gormley J. The prevalence of skeletal dysplasias. An estimate of their minimum frequency and the number of patients requiring orthopaedic care[J]. J Bone Joint Surg Br, 1985, 67(1): 133-137.
4Greenfield GB, Arrington JA. Imaging of bone tumors. Philadelphia[M]. Lippencott Williams &Wilkins, 1995: 325.
5Tueche SG, Gebhart M, Dewolf J, et al. Cranio-facial and humeral melorrheostosis[J]. Acta Chir Belg, 1999, 99(1): 47-50.
6Debeer" P, Pykels E, Lammens J, et al. Melorheostosis in a family with autosomal dominant osteopoikilosis: report of a third family[J]. Am J Med Genet A, 2003, 119A(2): 188-193.
7Endo H, Katsumi A, Kuroda K, et al. Increased pmconagen alphal (I) mRNA expression by dermal fibroblasts in melorheostosis[J]. Br J Dermatol, 2003, 148(4): 799-803.
8Hellemans J, Preobrazhenska O, Willaert A, et al. Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis[J]. Nat Genet, 2004, 36(11): 1213-1218.
9Hellemans J, Debeer P, Wright M, et al. Germline LEMD3 mutations are rare in sporadic patients with isolated melorheostosis[J]. Hum Mutat, 2006, 27(3): 290.
10Mumm S, Wankert D, Zlutng X, et al. Deactivating gerrnline mutations in LEMD3 cause osteopoikilosis and Buschke-Ollendorff syndrome, but not sporadic melorheostosis[J]. J Bone Miner Res,2007, 22(2): 243-250.
